GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TYK Medicines Inc (HKSE:02410) » Definitions » ROE % Adjusted to Book Value

TYK Medicines (HKSE:02410) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is TYK Medicines ROE % Adjusted to Book Value?

TYK Medicines's ROE % for the quarter that ended in Jun. 2024 was 0.00%. TYK Medicines's PB Ratio for the quarter that ended in Jun. 2024 was N/A. TYK Medicines's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.


TYK Medicines ROE % Adjusted to Book Value Historical Data

The historical data trend for TYK Medicines's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TYK Medicines ROE % Adjusted to Book Value Chart

TYK Medicines Annual Data
Trend Dec22 Dec23
ROE % Adjusted to Book Value
- -

TYK Medicines Quarterly Data
Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of TYK Medicines's ROE % Adjusted to Book Value

For the Biotechnology subindustry, TYK Medicines's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TYK Medicines's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TYK Medicines's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where TYK Medicines's ROE % Adjusted to Book Value falls into.



TYK Medicines ROE % Adjusted to Book Value Calculation

TYK Medicines's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

TYK Medicines's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TYK Medicines ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of TYK Medicines's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


TYK Medicines Business Description

Traded in Other Exchanges
N/A
Address
No. 1278 Mingzhu Road, Room 1403-2, Floor 14, Tower A, Changxing World Trade Building, Zhejiang Province, Changxing Economic Development Zone, Huzhou, CHN
TYK Medicines Inc is a drug discovery research and development centre. The company and its subsidiaries are principally engaged in the research, development and commercialization of pharmaceutical products.
Executives
Zhang Xing Xing Zhang Chan Ye Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Wu Yusheng 2201 Interest of corporation controlled by you
Zhu Julia Ming 2202 Interest of your spouse
Zheng Zhou Tai Ji Hong Nuo Yi Yao Gu Fen You Xian Gong Si 2101 Beneficial owner
Nan Jing Yi Da Tou Zi Guan Li You Xian Gong Si
Nan Jing Yi Da Zi Ben Guan Li Qi Ye You Xian He Huo
Jiang Su Yi Da Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si

TYK Medicines Headlines

No Headlines